Friday, 19 February 2016 |
||
|---|---|---|
| 09.00 – 13.00 | Meeting of Polish Myeloma Study Group | |
 |
13.00 – 14.00 | Lunch |
| 14.00 – 15.10 | 1st Session: Before We Start The Treatment Chairmen: Prof. Krzysztof Giannopoulos, Prof. Tomasz Wróbel |
|
| 14.00 – 14.20 | Current MM diagnostic criteria and definitions Prof. Krzysztof Giannopoulos |
|
| 14.20 – 14.40 | Pathophysiology of MM and targets for existing & future drugs and their combinations Prof. Roman Hajek |
|
| 14.40 – 15.00 | SMM (Smouldering Multiple Myeloma) - When to Treat? Prof. Wiesław Wiktor Jędrzejczak |
|
| 15.00 – 15.10 | Q&A | |
 |
15.10 – 15.30 | Coffee break |
| 15.30 – 16.20 | 2nd Session: NDMM (Newly Diagnosed Multiple Myeloma): current diagnostic & therapeutical recommemdations Chairmen: Prof. Andrzej Hellmann, Prof. Mieczysław Komarnicki |
|
| 15.30 – 15.50 | What’s new in the NSCT (Non-Stem Cell Transplant) Patients therapeutical recommendations? Prof. Krzysztof Jamroziak |
|
| 15.50 – 16.10 | What’s new in the SCT (Stem Cell Transplant) Patients therapeutical recommendations? Prof. Tomasz Wróbel |
|
| 16.10 – 16.20 | Q&A | |
| |
16.20 – 16.40 | Coffee break |
| 16.40 – 18.00 | 3rd Session: Practical aspects of RRMM Treatment (1) Chairmen: Prof. Iwona Hus, Prof. Roman Hajek |
|
| 16.40 – 17.00 | Sequential and Continued MM Treatment approach Prof. Roman Hajek |
|
| 17.00 – 17.20 | How to optimize MM Treatments through prevention and/or minimizing treatment complications and adverse events? Prof. Iwona Hus |
|
| 17.20 – 17.50 | RRMM Treatment New Opportunities Prof. Meletios Dimopoulos |
|
| 17.50 – 18.00 | Q&A | |
| |
19.00 | Dinner |
Saturday, 20 February 2016 |
||
|---|---|---|
| 9.00 – 10.20 | 4th Session: Practical aspects of RR MM Treatment (2) Chairmen: Prof. Anna Dmoszyńska, Prof. Jadwiga Dwilewicz-Trojaczek |
|
| 9.00 – 9.20 | Neurological complications in MM Treatment Prof. Michel Delforge |
|
| 9.20 – 9.40 | Stimulation of Immune system – new weapon to fight MM Prof. Krzysztof Giannopoulos |
|
| 9.40 – 10.10 | Proteasom inhibitors in MM treatment – current, future and Polish perspective Prof. Anna Dmoszyńska |
|
| 10.10 – 10.20 | Q&A | |
| |
10.20 – 10.40 | Coffee break |
| 10.40 – 11.50 | 5th Session: Comorbidities in MM Patients & New Therapeutic Opportunities Chairmen: Prof. Lidia Gil, Prof. Grzegorz Mazur |
|
| 10.40 – 11.00 | Neurosurgical & Orthopedics Prof. Rafał Załuski |
|
| 11.00 – 11.20 | Internal Medicine & Nephrology Prof. Grzegorz Mazur |
|
| 11.20 – 11.40 | Infections in MM Patients Prof. Lidia Gil |
|
| 11.40 – 11.50 | Q&A | |
| |
11.50 – 12.10 | Coffee break |
| 12.10 – 13.50 | 6th Session: What’s New in other haematological malignancies? Chairmen: Prof. Agnieszka Wierzbowska, Prof. Wiesław Wiktor Jędrzejczak |
|
| 12.10 – 12.30 | What’s new in amyloidosis treatment? Dr Grzegorz Charliński |
|
| 12.30 – 13.00 | Current position of Bortezomib in the treatment of plasma cell neoplasms Prof. Krzysztof Jamroziak |
|
| 13.00 – 13.20 | Immunomodulators in B-cell malignancies Dr med. Ewa Kalinka-Warzocha |
|
| 13.20 – 13.40 | Demethylating agents in MDS/AML treatment in elderly patients Prof. Agnieszka Wierzbowska |
|
| 13.40 – 13.50 | Q&A | |
| 13.50 – 14.00 | Remarks & Closing | |
| |
14.00 | Lunch |
18 Marca - Dzień III |
||
|---|---|---|
| 1015 - 1045 | Przywitanie uczestników konferencji | |
| 1045 - 1115 | Porta a lectus sed massa odio, viverra iaculis imperdiet vel Prof. dr hab. inż. Paweł Kamiński |
|
| 1115 - 1145 | Sed massa odio, viverra iaculis imperdiet vel, porta a lectus Prof. dr hab. inż. Paweł Kamiński |
|
|
1145 - 1215 | Przerwa kawowa |
| 1215 - 1245 | Viverra iaculis sed massa odio, imperdiet vel, porta a lectus dr hab. Maciej Mazur |
|
| 1245 - 1330 | Iaculis viverra porta a lectus sed massa odio, iaculis imperdiet vel dr hab. Maciej Mazur |
|
| |
1330 - 1415 | Lunch |
| 1415 - 1445 | Sed massa odio, viverra iaculis imperdiet vel, porta a lectus dr hab. Marta Dąbrowska |
|
| 1445 - 1600 | Porta a lectus sed massa odio, viverra iaculis imperdiet vel dr Zofia Wojciechowska |
|
